[{"AccountsPayableCurrent_0_Q2_USD":2392000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.01,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":69000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":67381000.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":218000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":1167000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_2_Q2_USD":-4000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_1_Q2_USD":9000.0,"OtherAssetsNoncurrent_0_Q2_USD":97000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":215000.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_2_Q2_USD":200000.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_1_Q2_USD":100000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":1567000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":1200000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":412000.0,"OperatingIncomeLoss_2_Q2_USD":-36513000.0,"OperatingIncomeLoss_1_Q2_USD":-17998000.0,"OperatingExpenses_2_Q2_USD":39054000.0,"OperatingExpenses_1_Q2_USD":19088000.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"NonoperatingIncomeExpense_2_Q2_USD":89000.0,"NonoperatingIncomeExpense_1_Q2_USD":34000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_2_Q2_USD":-36424000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q2_USD":-17964000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":-36424000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-17964000.0,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"NetIncomeLoss_2_Q2_USD":-36424000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockValue_0_Q2_USD":0.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":7226447.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":8106765.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense_2_Q2_USD":0.0,"UnrealizedGainLossOnInvestments_2_Q2_USD":-4000.0,"UnrealizedGainLossOnInvestments_1_Q2_USD":9000.0,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1_Q2_USD":0.0,"StockholdersEquity_0_Q2_USD":98912000.0,"ShortTermInvestments_0_Q2_USD":81597000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":2703614.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q2_shares":2291207.0,"ShareBasedCompensation_2_Q2_USD":6992000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_2_Q2_USD":2541000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q2_USD":1090000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-315311000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_2_Q2_USD":26371000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q2_USD":12565000.0,"RepaymentsOfNotesPayable_2_Q2_USD":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":298000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":2048000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_2_Q2_USD":75000.0,"ProceedsFromSaleOfMachineryAndEquipment_1_Q2_USD":75000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":67042000.0,"ProceedsFromNotesPayable_2_Q2_USD":0.0,"ProceedsFromIssuanceOfWarrants_2_Q2_USD":8529000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":4110000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"NetIncomeLoss_1_Q2_USD":-17964000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-26170000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-333000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-17955000.0,"CommonStockValue_0_Q2_USD":86000.0,"CommonStockSharesOutstanding_0_Q2_shares":8608886.0,"CommonStockSharesIssued_0_Q2_shares":8608886.0,"CommonStockSharesAuthorized_0_Q2_shares":200000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"CommitmentsAndContingencies_0_Q2_USD":null,"ClassOfWarrantOrRightOutstanding_0_Q2_shares":441545.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q2_USD":15.94,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-18192000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":27704000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":109300000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":120000.0,"AssetsCurrent_0_Q2_USD":115462000.0,"Assets_0_Q2_USD":118202000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":25827559.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":6992000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":3817000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":3817000.0,"AdditionalPaidInCapital_0_Q2_USD":259786000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-12000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":1750000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":278000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":14150000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-481000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-36428000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":288000.0,"DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_2_Q2_USD":0.0,"DepreciationDepletionAndAmortization_1_Q2_USD":25000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":8311000.0,"LiabilitiesCurrent_0_Q2_USD":16830000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":118202000.0,"Liabilities_0_Q2_USD":19290000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":1800000.0,"InterestPaidNet_2_Q2_USD":0.0,"InterestAndDebtExpense_2_Q2_USD":0.0,"InterestAndDebtExpense_1_Q2_USD":0.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":2156000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":5683000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":1601000.0,"IncomeTaxExaminationPenaltiesAndInterestExpense_2_Q2_USD":0.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":8106765.0,"IncomeTaxExaminationPenaltiesAndInterestExpense_1_Q2_USD":0.0,"ImpairmentOfLongLivedAssetsHeldForUse_1_Q2_USD":0.0,"GeneralAndAdministrativeExpense_2_Q2_USD":12683000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":6523000.0,"GainLossOnSaleOfPropertyPlantEquipment_2_Q2_USD":-67000.0,"GainLossOnDispositionOfAssets_1_Q2_USD":67000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q2_USD":36800000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":2566000.0,"EarningsPerShareDiluted_2_Q2_USD":-5.04,"EarningsPerShareDiluted_1_Q2_USD":-2.21,"EarningsPerShareBasic_2_Q2_USD":-5.04,"EarningsPerShareBasic_1_Q2_USD":-2.21,"DepreciationDepletionAndAmortization_2_Q2_USD":58000.0,"ImpairmentOfLongLivedAssetsHeldForUse_2_Q2_USD":0.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":7226447.0,"Ticker":"VRDN","CIK":"1590750","name":"VIRIDIAN THERAPEUTICS, INC.DE","OfficialName":"Viridian Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"445189274.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210812"}]